Announcements Trials

Browse Landscape

Status

Unknown 2 Terminated 1 Suspended 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Pain 7 Cancer Pain 4 Uterine Cervical Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Postoperative Complications 1 Ovarian Neoplasms 1 Neuralgia 1 Neoplasms 1 Malignant Female Reproductive System Neoplasm 1 Lymphoma, Follicular 1 Intraoperative Complications 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Emergencies 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Acute Pain 1

Interventions

Gemcitabine 109 Paclitaxel 92 Carboplatin 79 pembrolizumab 75 Bevacizumab 75 Surveys and Questionnaires 70 Docetaxel 69 Cisplatin 67 Nivolumab 48 Exercise 48 Capecitabine 48 Cyclophosphamide 47 Sorafenib 43 Fluorouracil 43 Irinotecan 42 Pemetrexed 37 Albumin-Bound Paclitaxel 35 Radiotherapy 34 Dexamethasone 34 Blood Specimen Collection 34 Oxaliplatin 31 Leucovorin 31 Erlotinib Hydrochloride 31 trametinib 30 130-nm albumin-bound paclitaxel 29 Cetuximab 28 Therapeutics 26 Ipilimumab 26 Standard of Care 25 Methods 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neoplasms × Hydromorphone × Clear all

NCT01946555 2016-04-14

RER

Mario Negri Institute for Pharmacological Research

Cancer Pain, Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡